Optic IconOptic Logo
|
SearchCollectionsBenchmarks
Organization

The Fifth Medical Center of PLA General Hospital

3 abstracts

Abstract
Comparative efficacy of six programmed cell death protein-1 inhibitors in first-line treatment for advanced non-small cell lung cancer: A retrospective cohort study.
Org: Senior Department of Oncology, The Fifth Medical Center of PLA General Hospital,
Abstract
A retrospective analysis of efficacy and safety of lenvatinib combined with PD-1 inhibitor and chemotherapy in advanced biliary tract cancer (BTC).
Org: The Fifth Medical Center of PLA General Hospital, Beijing InnoCare Pharma Tech, China National Biotec Group,
Abstract
Efficacy and safety of immune checkpoint inhibitor without pemetrexed for first-line maintenance therapy in advanced lung adenocarcinoma.
Org: Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) “Dino Amadori”, Meldola, Italy, Italy, The Fifth Medical Center of PLA General Hospital, School of Medicine, Nankai University, The First Medical Center of PLA General Hospital, Department of Oncology, the First Medical Center, Chinese PLA General Hospital,